Differential effects of lenalidomide during plasma cell differentiation

Thalidomide, lenalidomide and pomalidomide have greatly improved the outcome of patients with multiple myeloma. However, their effects on plasma cells, the healthy counterpart of myeloma cells, are unknown. Here, we investigated lenalidomide effects on normal human plasma cell generation using an in...

Descripción completa

Detalles Bibliográficos
Autores principales: Jourdan, Michel, Cren, Maïlys, Schafer, Peter, Robert, Nicolas, Duperray, Christophe, Vincent, Laure, Ceballos, Patrice, Cartron, Guillaume, Rossi, Jean-François, Moreaux, Jérôme, Chopra, Rajesh, Klein, Bernard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053712/
https://www.ncbi.nlm.nih.gov/pubmed/27057635
http://dx.doi.org/10.18632/oncotarget.8581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053712/
https://www.ncbi.nlm.nih.gov/pubmed/27057635
http://dx.doi.org/10.18632/oncotarget.8581

Ejemplares similares